Ontology type: schema:ScholarlyArticle Open Access: True
2001-03-01
AUTHORS ABSTRACTHeterotrimeric GTP-binding proteins (G protein) are known to participate in the transduction of signals from ligand activated receptors to effector molecules to elicit cellular responses. Sustained activation of cAMP-G protein signaling system by agonist results in desensitization of the pathway at receptor levels, however it is not clear whether such receptor responses induce other changes in post-receptor signaling path that are associated with maintenance of AMP levels, i.e. cAMP-forming adenylate cyclase (AC), cAMP-degrading cyclic nucleotide phosphodiesterase (PDE) and cAMP-dependent protein kinase (PKA). Experiments were performed to determine the expression of AC, PDE, and PKA isoforms in SH-SY5Y neuroblastoma cells, in which cAMP system was activated by expressing a constitutively activated mutant of stimulatory G protein (Q227L Gsα). Expression of ACI mRNA was increased, but levels of ACVIII and ACIX mRNA were decreased. All of the 4 expressed isoforms of PDE (PDE1C, PDE2, PDE 4A, and PDE4B) were increased in mRNA expression; the levels of PKA RIα, RIβ, and RIIβ were increased moderately, however, those of RIIα and Cα were increased remarkably. The activities of AC, PDE and PKA were also increased in the SH-SY5Y cells expressing Q227L Gsα. The similar changes in expression and activity of AC, PDE and PKA were observed in the SH-SY5Y cells treated with dbcAMP for 6 days. Consequently, it is concluded that the cAMP system adapts at the post-receptor level to a sustained activation of the system by differential expression of the isoforms of AC, PDE, and PKA in SH-SY5Y neuroblastoma. We also showed that an increase in cellular cAMP concentration might mediate the observed changes in the cAMP system. More... »
PAGES37-45
http://scigraph.springernature.com/pub.10.1038/emm.2001.8
DOIhttp://dx.doi.org/10.1038/emm.2001.8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1021549065
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/11322485
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Chemical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0304",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medicinal and Biomolecular Chemistry",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "3',5'-Cyclic-AMP Phosphodiesterases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adenylyl Cyclases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chromogranins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclic AMP",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclic AMP-Dependent Protein Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "GTP-Binding Protein alpha Subunits, Gs",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Heterotrimeric GTP-Binding Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Isoenzymes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Isoproterenol",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mutation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Nerve Tissue Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neuroblastoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Signal Transduction",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tumor Cells, Cultured",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Biochemistry and Cancer Research Institute, Seoul National University College of Medicine, Korea",
"id": "http://www.grid.ac/institutes/grid.31501.36",
"name": [
"Department of Biochemistry and Cancer Research Institute, Seoul National University College of Medicine, Korea"
],
"type": "Organization"
},
"familyName": "Jang",
"givenName": "Ik-Soon",
"id": "sg:person.01317070447.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317070447.13"
],
"type": "Person"
},
{
"familyName": "Juhnn",
"givenName": "Yong-Sung",
"id": "sg:person.01051451562.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051451562.78"
],
"type": "Person"
}
],
"datePublished": "2001-03-01",
"datePublishedReg": "2001-03-01",
"description": "Heterotrimeric GTP-binding proteins (G protein) are known to participate in the transduction of signals from ligand activated receptors to effector molecules to elicit cellular responses. Sustained activation of cAMP-G protein signaling system by agonist results in desensitization of the pathway at receptor levels, however it is not clear whether such receptor responses induce other changes in post-receptor signaling path that are associated with maintenance of AMP levels, i.e. cAMP-forming adenylate cyclase (AC), cAMP-degrading cyclic nucleotide phosphodiesterase (PDE) and cAMP-dependent protein kinase (PKA). Experiments were performed to determine the expression of AC, PDE, and PKA isoforms in SH-SY5Y neuroblastoma cells, in which cAMP system was activated by expressing a constitutively activated mutant of stimulatory G protein (Q227L Gs\u03b1). Expression of ACI mRNA was increased, but levels of ACVIII and ACIX mRNA were decreased. All of the 4 expressed isoforms of PDE (PDE1C, PDE2, PDE 4A, and PDE4B) were increased in mRNA expression; the levels of PKA RI\u03b1, RI\u03b2, and RII\u03b2 were increased moderately, however, those of RII\u03b1 and C\u03b1 were increased remarkably. The activities of AC, PDE and PKA were also increased in the SH-SY5Y cells expressing Q227L Gs\u03b1. The similar changes in expression and activity of AC, PDE and PKA were observed in the SH-SY5Y cells treated with dbcAMP for 6 days. Consequently, it is concluded that the cAMP system adapts at the post-receptor level to a sustained activation of the system by differential expression of the isoforms of AC, PDE, and PKA in SH-SY5Y neuroblastoma. We also showed that an increase in cellular cAMP concentration might mediate the observed changes in the cAMP system.",
"genre": "article",
"id": "sg:pub.10.1038/emm.2001.8",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1085098",
"issn": [
"1226-3613",
"2092-6413"
],
"name": "Experimental & Molecular Medicine",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "33"
}
],
"keywords": [
"protein kinase",
"SH-SY5Y neuroblastoma cells",
"SH-SY5Y cells",
"cAMP-dependent protein kinase",
"activity of AC",
"sustained activation",
"transduction of signals",
"elicit cellular responses",
"PKA isoforms",
"neuroblastoma cells",
"adenylate cyclase",
"heterotrimeric GTP",
"isoforms of phosphodiesterase",
"cellular cAMP concentration",
"PKA RI\u03b1",
"G protein",
"SH-SY5Y neuroblastoma",
"stimulatory G protein",
"cellular responses",
"stimulatory G protein \u03b1",
"differential expression",
"protein \u03b1",
"effector molecules",
"cyclic nucleotide phosphodiesterase",
"protein",
"isoforms",
"post-receptor level",
"expression",
"nucleotide phosphodiesterase",
"phosphodiesterase",
"cAMP concentration",
"Gs\u03b1",
"mRNA",
"cells",
"cAMP",
"mRNA expression",
"cAMP system",
"RII\u03b1",
"RI\u03b1",
"RII\u03b2",
"activation",
"agonists results",
"mutants",
"RI\u03b2",
"receptor responses",
"transduction",
"kinase",
"GTP",
"pathway",
"observed changes",
"receptor levels",
"C\u03b1",
"activity",
"AMP levels",
"cyclase",
"similar changes",
"adaptation",
"receptors",
"levels",
"response",
"maintenance",
"molecules",
"changes",
"dbcAMP",
"ligands",
"desensitization",
"signals",
"neuroblastoma",
"system",
"experiments",
"concentration",
"increase",
"days",
"results",
"path"
],
"name": "Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein \u03b1, Q227L Gs\u03b1",
"pagination": "37-45",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1021549065"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/emm.2001.8"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"11322485"
]
}
],
"sameAs": [
"https://doi.org/10.1038/emm.2001.8",
"https://app.dimensions.ai/details/publication/pub.1021549065"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:21",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_330.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/emm.2001.8"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/emm.2001.8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/emm.2001.8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/emm.2001.8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/emm.2001.8'
This table displays all metadata directly associated to this object as RDF triples.
203 TRIPLES
21 PREDICATES
116 URIs
108 LITERALS
22 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1038/emm.2001.8 | schema:about | N0c3262d16860482abc6107aa6a679f33 |
2 | ″ | ″ | N0f6966eac3dc43588297d108611ba274 |
3 | ″ | ″ | N11e5a9054d944ee68aa4e2e8ebfb4928 |
4 | ″ | ″ | N3e25a90113e64bb4978292aad8e4ac5c |
5 | ″ | ″ | N4384960782a442588b8597d132750097 |
6 | ″ | ″ | N50f1fd2d37ff46b7983d8002aa027c58 |
7 | ″ | ″ | N51d812e7a5b8479f9b0dba3f4ff1422f |
8 | ″ | ″ | N599a87fe4dc446aebcb36dafc73152d5 |
9 | ″ | ″ | N5ce0c244bc224121976df625387674dd |
10 | ″ | ″ | N6ff2bdc35c614f5da89ec1c6f6fc456c |
11 | ″ | ″ | N88a2c5212a80404188c624cea935b5a3 |
12 | ″ | ″ | N923c67b41103417b8088a3c3cf553276 |
13 | ″ | ″ | N963428f967434ddb9403085cab335400 |
14 | ″ | ″ | Naeb30c3c868c4eb5b10f3c760cc63298 |
15 | ″ | ″ | Nd6025287842d4017989c67d5fd729584 |
16 | ″ | ″ | anzsrc-for:03 |
17 | ″ | ″ | anzsrc-for:0304 |
18 | ″ | schema:author | N4aaed393317e415487a17b128dcb6266 |
19 | ″ | schema:datePublished | 2001-03-01 |
20 | ″ | schema:datePublishedReg | 2001-03-01 |
21 | ″ | schema:description | Heterotrimeric GTP-binding proteins (G protein) are known to participate in the transduction of signals from ligand activated receptors to effector molecules to elicit cellular responses. Sustained activation of cAMP-G protein signaling system by agonist results in desensitization of the pathway at receptor levels, however it is not clear whether such receptor responses induce other changes in post-receptor signaling path that are associated with maintenance of AMP levels, i.e. cAMP-forming adenylate cyclase (AC), cAMP-degrading cyclic nucleotide phosphodiesterase (PDE) and cAMP-dependent protein kinase (PKA). Experiments were performed to determine the expression of AC, PDE, and PKA isoforms in SH-SY5Y neuroblastoma cells, in which cAMP system was activated by expressing a constitutively activated mutant of stimulatory G protein (Q227L Gsα). Expression of ACI mRNA was increased, but levels of ACVIII and ACIX mRNA were decreased. All of the 4 expressed isoforms of PDE (PDE1C, PDE2, PDE 4A, and PDE4B) were increased in mRNA expression; the levels of PKA RIα, RIβ, and RIIβ were increased moderately, however, those of RIIα and Cα were increased remarkably. The activities of AC, PDE and PKA were also increased in the SH-SY5Y cells expressing Q227L Gsα. The similar changes in expression and activity of AC, PDE and PKA were observed in the SH-SY5Y cells treated with dbcAMP for 6 days. Consequently, it is concluded that the cAMP system adapts at the post-receptor level to a sustained activation of the system by differential expression of the isoforms of AC, PDE, and PKA in SH-SY5Y neuroblastoma. We also showed that an increase in cellular cAMP concentration might mediate the observed changes in the cAMP system. |
22 | ″ | schema:genre | article |
23 | ″ | schema:inLanguage | en |
24 | ″ | schema:isAccessibleForFree | true |
25 | ″ | schema:isPartOf | N31ee574bd85246dea4b3ffb77ba141ee |
26 | ″ | ″ | Ncc68631a4d494d1aa290a6bd41163aea |
27 | ″ | ″ | sg:journal.1085098 |
28 | ″ | schema:keywords | AMP levels |
29 | ″ | ″ | Cα |
30 | ″ | ″ | G protein |
31 | ″ | ″ | GTP |
32 | ″ | ″ | Gsα |
33 | ″ | ″ | PKA RIα |
34 | ″ | ″ | PKA isoforms |
35 | ″ | ″ | RIIα |
36 | ″ | ″ | RIIβ |
37 | ″ | ″ | RIα |
38 | ″ | ″ | RIβ |
39 | ″ | ″ | SH-SY5Y cells |
40 | ″ | ″ | SH-SY5Y neuroblastoma |
41 | ″ | ″ | SH-SY5Y neuroblastoma cells |
42 | ″ | ″ | activation |
43 | ″ | ″ | activity |
44 | ″ | ″ | activity of AC |
45 | ″ | ″ | adaptation |
46 | ″ | ″ | adenylate cyclase |
47 | ″ | ″ | agonists results |
48 | ″ | ″ | cAMP |
49 | ″ | ″ | cAMP concentration |
50 | ″ | ″ | cAMP system |
51 | ″ | ″ | cAMP-dependent protein kinase |
52 | ″ | ″ | cells |
53 | ″ | ″ | cellular cAMP concentration |
54 | ″ | ″ | cellular responses |
55 | ″ | ″ | changes |
56 | ″ | ″ | concentration |
57 | ″ | ″ | cyclase |
58 | ″ | ″ | cyclic nucleotide phosphodiesterase |
59 | ″ | ″ | days |
60 | ″ | ″ | dbcAMP |
61 | ″ | ″ | desensitization |
62 | ″ | ″ | differential expression |
63 | ″ | ″ | effector molecules |
64 | ″ | ″ | elicit cellular responses |
65 | ″ | ″ | experiments |
66 | ″ | ″ | expression |
67 | ″ | ″ | heterotrimeric GTP |
68 | ″ | ″ | increase |
69 | ″ | ″ | isoforms |
70 | ″ | ″ | isoforms of phosphodiesterase |
71 | ″ | ″ | kinase |
72 | ″ | ″ | levels |
73 | ″ | ″ | ligands |
74 | ″ | ″ | mRNA |
75 | ″ | ″ | mRNA expression |
76 | ″ | ″ | maintenance |
77 | ″ | ″ | molecules |
78 | ″ | ″ | mutants |
79 | ″ | ″ | neuroblastoma |
80 | ″ | ″ | neuroblastoma cells |
81 | ″ | ″ | nucleotide phosphodiesterase |
82 | ″ | ″ | observed changes |
83 | ″ | ″ | path |
84 | ″ | ″ | pathway |
85 | ″ | ″ | phosphodiesterase |
86 | ″ | ″ | post-receptor level |
87 | ″ | ″ | protein |
88 | ″ | ″ | protein kinase |
89 | ″ | ″ | protein α |
90 | ″ | ″ | receptor levels |
91 | ″ | ″ | receptor responses |
92 | ″ | ″ | receptors |
93 | ″ | ″ | response |
94 | ″ | ″ | results |
95 | ″ | ″ | signals |
96 | ″ | ″ | similar changes |
97 | ″ | ″ | stimulatory G protein |
98 | ″ | ″ | stimulatory G protein α |
99 | ″ | ″ | sustained activation |
100 | ″ | ″ | system |
101 | ″ | ″ | transduction |
102 | ″ | ″ | transduction of signals |
103 | ″ | schema:name | Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein α, Q227L Gsα |
104 | ″ | schema:pagination | 37-45 |
105 | ″ | schema:productId | N431cbdc16553471eaa52440bfba4ede4 |
106 | ″ | ″ | N926f92ef765f4c229de6c247547adfdb |
107 | ″ | ″ | Nd871478ff0344a6abfcb57a1b743919b |
108 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1021549065 |
109 | ″ | ″ | https://doi.org/10.1038/emm.2001.8 |
110 | ″ | schema:sdDatePublished | 2022-05-20T07:21 |
111 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
112 | ″ | schema:sdPublisher | N1769c1ef65e74b88903d9ff9209424a6 |
113 | ″ | schema:url | https://doi.org/10.1038/emm.2001.8 |
114 | ″ | sgo:license | sg:explorer/license/ |
115 | ″ | sgo:sdDataset | articles |
116 | ″ | rdf:type | schema:ScholarlyArticle |
117 | N0c3262d16860482abc6107aa6a679f33 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
118 | ″ | schema:name | Isoproterenol |
119 | ″ | rdf:type | schema:DefinedTerm |
120 | N0f6966eac3dc43588297d108611ba274 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
121 | ″ | schema:name | Mutation |
122 | ″ | rdf:type | schema:DefinedTerm |
123 | N11e5a9054d944ee68aa4e2e8ebfb4928 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
124 | ″ | schema:name | Humans |
125 | ″ | rdf:type | schema:DefinedTerm |
126 | N1769c1ef65e74b88903d9ff9209424a6 | schema:name | Springer Nature - SN SciGraph project |
127 | ″ | rdf:type | schema:Organization |
128 | N31ee574bd85246dea4b3ffb77ba141ee | schema:volumeNumber | 33 |
129 | ″ | rdf:type | schema:PublicationVolume |
130 | N3e25a90113e64bb4978292aad8e4ac5c | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
131 | ″ | schema:name | Cyclic AMP |
132 | ″ | rdf:type | schema:DefinedTerm |
133 | N431cbdc16553471eaa52440bfba4ede4 | schema:name | doi |
134 | ″ | schema:value | 10.1038/emm.2001.8 |
135 | ″ | rdf:type | schema:PropertyValue |
136 | N4384960782a442588b8597d132750097 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
137 | ″ | schema:name | Nerve Tissue Proteins |
138 | ″ | rdf:type | schema:DefinedTerm |
139 | N4aaed393317e415487a17b128dcb6266 | rdf:first | sg:person.01317070447.13 |
140 | ″ | rdf:rest | Nc6083e84375648adacaff6d90c08cf12 |
141 | N50f1fd2d37ff46b7983d8002aa027c58 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
142 | ″ | schema:name | Adenylyl Cyclases |
143 | ″ | rdf:type | schema:DefinedTerm |
144 | N51d812e7a5b8479f9b0dba3f4ff1422f | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
145 | ″ | schema:name | Heterotrimeric GTP-Binding Proteins |
146 | ″ | rdf:type | schema:DefinedTerm |
147 | N599a87fe4dc446aebcb36dafc73152d5 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
148 | ″ | schema:name | Isoenzymes |
149 | ″ | rdf:type | schema:DefinedTerm |
150 | N5ce0c244bc224121976df625387674dd | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
151 | ″ | schema:name | Tumor Cells, Cultured |
152 | ″ | rdf:type | schema:DefinedTerm |
153 | N6ff2bdc35c614f5da89ec1c6f6fc456c | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
154 | ″ | schema:name | 3',5'-Cyclic-AMP Phosphodiesterases |
155 | ″ | rdf:type | schema:DefinedTerm |
156 | N88a2c5212a80404188c624cea935b5a3 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
157 | ″ | schema:name | Cyclic AMP-Dependent Protein Kinases |
158 | ″ | rdf:type | schema:DefinedTerm |
159 | N923c67b41103417b8088a3c3cf553276 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
160 | ″ | schema:name | Neuroblastoma |
161 | ″ | rdf:type | schema:DefinedTerm |
162 | N926f92ef765f4c229de6c247547adfdb | schema:name | pubmed_id |
163 | ″ | schema:value | 11322485 |
164 | ″ | rdf:type | schema:PropertyValue |
165 | N963428f967434ddb9403085cab335400 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
166 | ″ | schema:name | GTP-Binding Protein alpha Subunits, Gs |
167 | ″ | rdf:type | schema:DefinedTerm |
168 | Naeb30c3c868c4eb5b10f3c760cc63298 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
169 | ″ | schema:name | Signal Transduction |
170 | ″ | rdf:type | schema:DefinedTerm |
171 | Nc6083e84375648adacaff6d90c08cf12 | rdf:first | sg:person.01051451562.78 |
172 | ″ | rdf:rest | rdf:nil |
173 | Ncc68631a4d494d1aa290a6bd41163aea | schema:issueNumber | 1 |
174 | ″ | rdf:type | schema:PublicationIssue |
175 | Nd6025287842d4017989c67d5fd729584 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
176 | ″ | schema:name | Chromogranins |
177 | ″ | rdf:type | schema:DefinedTerm |
178 | Nd871478ff0344a6abfcb57a1b743919b | schema:name | dimensions_id |
179 | ″ | schema:value | pub.1021549065 |
180 | ″ | rdf:type | schema:PropertyValue |
181 | anzsrc-for:03 | schema:inDefinedTermSet | anzsrc-for: |
182 | ″ | schema:name | Chemical Sciences |
183 | ″ | rdf:type | schema:DefinedTerm |
184 | anzsrc-for:0304 | schema:inDefinedTermSet | anzsrc-for: |
185 | ″ | schema:name | Medicinal and Biomolecular Chemistry |
186 | ″ | rdf:type | schema:DefinedTerm |
187 | sg:journal.1085098 | schema:issn | 1226-3613 |
188 | ″ | ″ | 2092-6413 |
189 | ″ | schema:name | Experimental & Molecular Medicine |
190 | ″ | schema:publisher | Springer Nature |
191 | ″ | rdf:type | schema:Periodical |
192 | sg:person.01051451562.78 | schema:familyName | Juhnn |
193 | ″ | schema:givenName | Yong-Sung |
194 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051451562.78 |
195 | ″ | rdf:type | schema:Person |
196 | sg:person.01317070447.13 | schema:affiliation | grid-institutes:grid.31501.36 |
197 | ″ | schema:familyName | Jang |
198 | ″ | schema:givenName | Ik-Soon |
199 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317070447.13 |
200 | ″ | rdf:type | schema:Person |
201 | grid-institutes:grid.31501.36 | schema:alternateName | Department of Biochemistry and Cancer Research Institute, Seoul National University College of Medicine, Korea |
202 | ″ | schema:name | Department of Biochemistry and Cancer Research Institute, Seoul National University College of Medicine, Korea |
203 | ″ | rdf:type | schema:Organization |